MOTS-c (injection)

You’ll pay $199 when you pre-order. We’ll review your prescription request when we’re ready to ship. If approved, your next $199 payment will be charged 30 days after approval, then every 30 days after that.

Our commitment to quality comes before speed. We’re taking the time to ensure our peptides meet our standards before they ship. Preorder today to reserve your place in the first wave.

MOTS-c is a mitochondria-derived peptide being studied for its role in how cells use energy and regulate metabolism. Researchers are exploring its potential effects on glucose metabolism, exercise capacity and healthy aging. Its use as a treatment remains investigational.

Research is still early. We don’t yet have enough human evidence to know whether MOTS-c treatment improves energy, supports weight loss or extends lifespan. Your clinician can help you understand the research and what remains unknown. If you’re experiencing new or unexplained fatigue, they can also help assess potential causes.

No. MOTS-c is a different type of peptide and is not an established replacement for prescribed diabetes or weight-management treatment. Continue taking your prescribed medications unless your clinician recommends a change.

Under Superpower’s current protocol, MOTS-c is not offered to people who are taking, or have taken within the past three months, a GLP-1 medication, metformin or an SGLT2 inhibitor. Other glucose-lowering medications, including insulin and sulfonylureas, require individual clinical review. The three-month requirement is specific to our program; it does not establish a universally safe interval between treatments. Please don’t stop a prescribed medication to meet this requirement.

No. You can start MOTS-c without labs. You will be prompted to complete labs within the first 60 days of your cycle. There will be monitoring labs every 6 months. You may upload past labs prior to starting treatment if you would like your clinician to review them.

MOTS-c is a twice weekly injection, with doses kept 3-4 days apart. Your clinician will confirm your prescribed dose and schedule. Any changes to your dose should be agreed with them first.

The planned cycle is 12 weeks, followed by a 4-week break. Your clinician may stop treatment earlier if it isn’t helping or a safety concern comes up, and continuing after the break needs their reassessment and approval.

MOTS-c’s safety in humans has not been established, and its potential side effects and longer-term risks are not fully understood. Contact your care team promptly if you experience new fatigue, injection-site reactions, rash, dizziness, shakiness, sweating, weakness or confusion. Some of these symptoms can indicate low blood sugar and need clinical attention, particularly with glucose-lowering medications, fasting or exercise. Seek emergency care for severe confusion, fainting, seizures or difficulty breathing.

You’ll complete symptom check-ins every four weeks. During continued care, the protocol also includes CBC/CMP bloodwork every six months, along with any additional testing your clinician requires. These check-ins help guide decisions about ongoing treatment. New symptoms, medication changes or overdue monitoring may mean treatment needs to be paused or stopped.

$199 a month, inclusive of any labs, clinician messaging and use of Superpower AI.